← Back to Clinical Trials
Recruiting NCT07129070

NCT07129070 Just-in-Time Training for Youth Mentors

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07129070
Status Recruiting
Phase
Sponsor University of Minnesota
Condition Mental Health Issue
Study Type INTERVENTIONAL
Enrollment 204 participants
Start Date 2025-12-18
Primary Completion 2028-04-01

Eligibility & Interventions

Sex All sexes
Min Age 12 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Interpersonal Psychotherapy-Adolescent Skills Training via Just-In-Time Training (JITT) implementation strategyInterpersonal Psychotherapy-Adolescent Skills Training (IPT-AST) implemented via usual training

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 204 participants in total. It began in 2025-12-18 with a primary completion date of 2028-04-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study will evaluate the usability, feasibility, and acceptability of a novel multi-level Just-In-Time Training (JITT) implementation strategy (JITT-EBP) that aims to equip mentors and mentor supervisors to implement evidence-based practices (EBPs) with fidelity using methods that are sustainable in rural communities. JITT-EBP integrates (a) self-directed, on-demand, online training modules for mentors and mentor supervisors, (b) synchronous evidence-based supervision strategies, and (c) an apprenticeship delivery model in which EBPs are co-led by an experienced mentor and a novice mentor, providing opportunity for in-the-moment training and support. The study will conduct a pilot hybrid type 2 effectiveness-implementation trial to evaluate the use of JITT-EBP compared to usual training for implementing mentor-delivered Interpersonal Psychotherapy-Adolescent Skills Training (IPT-AST), an evidence-based depression prevention program. 96 adolescents (age 12-17) and their parents, 8-18 mentors (depending on amount of turnover), and 4 mentor supervisors will be enrolled in the trial.

Eligibility Criteria

Youth and Parent Inclusion Criteria: * student at a partnering rural middle school or high school * age 12-17 * have English speaking/reading/writing ability at a level to participate in IPT-AST * youth's parent has English or Spanish-speaking/reading/writing ability at a level to participate in research activities. Youth and Parent Exclusion Criteria: * moderate or severe depression (PHQ-9 \> 10) * active suicidal ideation with a plan and/or intent, requiring higher level of care * Youth does not have English-speaking ability at a level to participate in IPT-AST * youth's parent does not have English or Spanish-speaking/reading/writing ability at a level to participate in research activities. Mentor and Mentor Supervisor Inclusion Criteria: * age 18 or older * have completed the typical mentor or mentor supervisor screening and selection process at partnering mentoring organization (including a background check) * are available to facilitate the program during after-school hours.

Contact & Investigator

Central Contact

Gracie Meyer

✉ meye3329@umn.edu

📞 612-625-7240

Principal Investigator

Meredith Gunlicks-Stoessel, PhD, LP

PRINCIPAL INVESTIGATOR

University of Minnesota

Frequently Asked Questions

Who can join the NCT07129070 clinical trial?

This trial is open to participants of all sexes, aged 12 Years or older, studying Mental Health Issue. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07129070 currently recruiting?

Yes, NCT07129070 is actively recruiting participants. Contact the research team at meye3329@umn.edu for enrollment information.

Where is the NCT07129070 trial being conducted?

This trial is being conducted at Minneapolis, United States.

Who is sponsoring the NCT07129070 clinical trial?

NCT07129070 is sponsored by University of Minnesota. The principal investigator is Meredith Gunlicks-Stoessel, PhD, LP at University of Minnesota. The trial plans to enroll 204 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology